JV Public Relations NY
Call now
Call now
Website
Call
JV Public Relations NY
There was a time where public relations was heavily dependent on the wording of your press releases or emails because you were limited to text to tell your story, but that's no longer the case. We can help you tell your story. Whether it is building awareness, gaining physician adoption, or supporting clinical development.

Public relations is an important value. With decades of experience and a great track record of successfully communicating the value of public and private companies in the emerging growth space, JVPRNY continues to boldly pioneer new methods of reaching your target audience. We are a New York City certified Minority/Women Business Enterprise (M/WBE) and Women Owned Small Business (WOSB) Federally-Certified.
Services
With decades of experience and a great track record of successfully communicating the value of public and private companies in the emerging growth space, JVPRNY continues to boldly pioneer new methods of reaching your target audience. Angelo is our lead writer, editor and consultant servicing the pharma, biotech, chemical and healthcare industries.
How do you stack up to the competition? How is your cancer drug any different from what is out there? Defining your brand's core messages takes time. Working with pros takes the guesswork! We understand message development, have strong relationships across multiple healthcare communication channels.
Financial opportunities move quicker than ever. New companies are born and venerable ones fall. That's the way it goes. Now, more than ever, financial companies need to be educating the investing public in order to help them navigate the ever changing investing landscape. That's where where our strategic division partner, BlueChip PR come in.
Cannabis is now legal in some form (medical or recreational) in 29 states. We are seeing more pharmaceutical companies entering this space. The pharmaceutical industry is gingerly placing more bets on developing drugs that target the endocannabinoid system. Drug companies are starting to invest more time and money in cannabis research now that 33 states and D.C. allow medical marijuana.
Reviews
Review JV Public Relations NY

Be the first to review JV Public Relations NY.

Write a Review